Target validation: switching domains

Alessio Ciulli (Lead / Corresponding author)

Research output: Contribution to journalShort surveypeer-review

264 Downloads (Pure)


Chemical probes and drugs often bind to functional domains on disease-relevant proteins. A study suggests a chemical genetic approach to establish on-target effects by swapping the targeted domain, affording resistance to pharmacological inhibition while retaining functionality.
Original languageEnglish
Pages (from-to)659-660
Number of pages2
JournalNature Chemical Biology
Issue number9
Early online date18 Aug 2016
Publication statusPublished - Sept 2016


  • Cancer therapy
  • Chemical genetics
  • Small molecules
  • Target validation
  • Transcription


Dive into the research topics of 'Target validation: switching domains'. Together they form a unique fingerprint.

Cite this